(Q39043026)

English

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies

scientific article published on 3 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

anti-retroviral agent

0 references

Sub-Saharan Africa

1 reference

based on heuristic

inferred from title

5

object named as

Cissy Kityo

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Tobias F Rinke de Wit

13

object named as

Tobias F Rinke de Wit

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1

object named as

Raph L Hamers

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

8

object named as

Prudence Ive

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Wendy S Stevens

12

object named as

Wendy S Stevens

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Carole L Wallis

4

object named as

Carole L Wallis

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Kim C E Sigaloff

2

object named as

Kim C E Sigaloff

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Margaret Siwale

6

object named as

Margaret Siwale

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Mariette E Botes

9

object named as

Mariette E Botes

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

11

object named as

Akin Osibogun

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Kishor Mandaliya

7

object named as

Kishor Mandaliya

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

10

object named as

Maureen Wellington

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PharmAccess African Studies to Evaluate Resistance (PASER)

15

object named as

PharmAccess African Studies to Evaluate Resistance (PASER)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Annemarie M J Wensing

3

object named as

Annemarie M Wensing

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Rob Schuurman

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

3 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1660-1669

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

A statistical model for HIV-1 sequence classification using the subtype analyser (STAR).

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

An automated genotyping system for analysis of HIV-1 and other microbial sequences

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Web resources for HIV type 1 genotypic-resistance test interpretation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

High rates of survival, immune reconstitution, and virologic suppression on second-line antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Outcomes after virologic failure of first-line ART in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Early versus standard antiretroviral therapy for HIV-infected adults in Haiti

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS254

21 January 2018

Identifiers

10.1093/CID/CIS254

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

release_flgfr3rcuneftkeukrqgepvjzi

1 reference

https://api.fatcat.wiki/v0/release/flgfr3rcuneftkeukrqgepvjzi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39043026&oldid=1858786141"